Fair enough, but with that proposal you have the FDA and pharmaceutical companies positioned against you.

Price controls - at least with a Democratic administration - are more realistic, because the FDA doesn't care about that and the pharmaceutical companies at least get to keep their moat, which they will prefer over some lost profits from generics.